Promethera Biosciences

About:

Promethera Biosciences is a biopharmaceutical company focused on cell therapy products to treat liver diseases.

Website: https://www.promethera.com/

Twitter/X: promethera

Top Investors: Mitsubishi UFJ Capital, EQT Life Sciences, Boehringer Ingelheim Venture Fund, Sony Innovation Fund, Shinsei Corporate Investment

Description:

Promethera® Biosciences is a biopharmaceutical company, spin-off of the Université Catholique de Louvain, that develops innovative treatments based on allogeneic adult stem cell technology. Promethera® Biosciences' mission is to discover, develop and commercialize cell therapy products to treat liver diseases in an innovative way using allogenic progenitor cells from healthy human livers. Promethera® Biosciences develops two products based on a newly discovered and patented progenitor cell type: the human Adult Liver-Derived Mesenchymal Progenitor Cell (hALDMSC):